Company Filing History:
Years Active: 1989
Title: Teruyoshi Marunaka: Innovator in Anti-Leukemia Compounds
Introduction
Teruyoshi Marunaka is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-leukemia activity. His work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Marunaka holds 2 patents, with his latest patents focusing on a compound known as Substance 4181-2 and its derivatives. These compounds are characterized by a general formula where R₁ and R₂ can represent a hydrogen atom, an alkyl group, or an acyl group. The disclosed compounds exhibit antitumor activity, and those where both R₁ and R₂ are hydrogen atoms or acyl groups are considered novel. The innovative nature of these compounds highlights Marunaka's commitment to advancing cancer treatment.
Career Highlights
Marunaka is associated with Taiho Pharmaceutical Company Limited, where he has been instrumental in research and development. His work at Taiho Pharmaceutical has allowed him to focus on creating effective treatments for leukemia and other cancers. His dedication to innovation in pharmaceuticals is evident through his research and patent filings.
Collaborations
Some of his notable coworkers include Qi Chang-qing and Tian Jie. Their collaboration has likely contributed to the success of Marunaka's research and the development of new therapeutic compounds.
Conclusion
Teruyoshi Marunaka is a prominent figure in the field of pharmaceutical innovation, particularly in the development of anti-leukemia compounds. His patents and work at Taiho Pharmaceutical Company Limited reflect his dedication to improving cancer treatment. The impact of his research may lead to significant advancements in oncology.